|
US5939262A
(en)
*
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
|
DE19737442C2
(de)
*
|
1997-08-22 |
1999-06-24 |
Olfert Landt Tib Molbiol Synth |
Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
US20030083272A1
(en)
*
|
1997-09-19 |
2003-05-01 |
Lahive & Cockfield, Llp |
Sense mrna therapy
|
|
EP1892299A3
(en)
*
|
1997-09-19 |
2011-07-20 |
Life Technologies Corporation |
Sense mRNA therapy
|
|
US7767422B2
(en)
*
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
|
US6777210B1
(en)
*
|
1998-09-24 |
2004-08-17 |
Ambion, Inc. |
Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1
|
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
KR20000065690A
(ko)
*
|
1999-04-08 |
2000-11-15 |
박종구 |
반응 특이성 및 안정성을 개선시킨 안티센스 올리고 뉴클레오타이드, 안티센스 ｄｎａ 및 그 제조방법
|
|
US7829693B2
(en)
*
|
1999-11-24 |
2010-11-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
CA2402452A1
(en)
*
|
2000-03-31 |
2001-10-11 |
Cambridge Antibody Technology Limited |
Improvements to ribosome display
|
|
AU2001285157A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Oncomedx, Inc. |
5t4 rna in plasma and serum as a marker for neoplastic disease
|
|
GB0021303D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Medinnova Sf |
Use
|
|
RU2189396C2
(ru)
*
|
2000-10-27 |
2002-09-20 |
Федеральное государственное учреждение науки и здравоохранения Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. акад. И.Н.Блохиной |
Способ обнаружения и дифференциации рнк энтеровирусов
|
|
US8546143B2
(en)
|
2001-01-09 |
2013-10-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
US20020172972A1
(en)
*
|
2001-05-15 |
2002-11-21 |
President And Fellows Of Harvard College |
Use of a selectively inactivatable enzyme to digest contaminating nucleic acid
|
|
WO2003050308A1
(en)
*
|
2001-12-06 |
2003-06-19 |
The Aaron Diamond Aids Research Center |
Highly-sensitive genomic assays employing chimeric bacteriophage standards
|
|
EP1476573B1
(en)
|
2002-01-28 |
2010-01-06 |
Ambion, Inc. |
Crude biological derivatives competent for nucleic acid detection
|
|
ATE556714T1
(de)
|
2002-02-01 |
2012-05-15 |
Life Technologies Corp |
Doppelsträngige oligonukleotide
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
US7482116B2
(en)
|
2002-06-07 |
2009-01-27 |
Dna Genotek Inc. |
Compositions and methods for obtaining nucleic acids from sputum
|
|
JP2006507800A
(ja)
*
|
2002-06-07 |
2006-03-09 |
ラージ・スケール・バイオロジー・コーポレイション |
可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
|
|
WO2004085611A2
(en)
*
|
2003-03-21 |
2004-10-07 |
The Research Foundation Of State University Of New York |
Model for mutually exclusive domain folding molecular switch
|
|
ATE488604T1
(de)
*
|
2003-05-20 |
2010-12-15 |
Investigen Inc |
System zum nachweis von polynukleotiden
|
|
EP1692153A4
(en)
|
2003-07-03 |
2007-03-21 |
Univ Pennsylvania |
INHIBITION OF EXPRESSION OF SYK-KINASE
|
|
DE602004026912D1
(de)
*
|
2003-12-16 |
2010-06-10 |
Qiagen North American Holdings |
Formulierungen und verfahren zum denaturieren von proteinen
|
|
JP2007531794A
(ja)
*
|
2004-04-05 |
2007-11-08 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
オリゴヌクレオチドの合成および精製に使用する方法および反応試薬
|
|
EP1768998A2
(en)
|
2004-04-27 |
2007-04-04 |
Alnylam Pharmaceuticals Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
AU2005323437B2
(en)
*
|
2004-04-30 |
2011-10-06 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a C5-modified pyrimidine
|
|
EP1789553B1
(en)
*
|
2004-06-30 |
2014-03-26 |
Alnylam Pharmaceuticals Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
|
WO2006093526A2
(en)
*
|
2004-07-21 |
2006-09-08 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
AU2005330637B2
(en)
|
2004-08-04 |
2012-09-20 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
|
|
US7309589B2
(en)
|
2004-08-20 |
2007-12-18 |
Vironix Llc |
Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
|
|
EP2309269B1
(en)
*
|
2004-09-08 |
2016-10-26 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions and methods for the detection of HIV-1/HIV-2 infection.
|
|
WO2006045591A2
(en)
*
|
2004-10-25 |
2006-05-04 |
Devgen N.V. |
Method and constructs for delivering double stranded rna to pest organisms
|
|
US20060105372A1
(en)
|
2004-11-05 |
2006-05-18 |
Bair Robert J |
Compositions and methods for purifying nucleic acids from stabilization reagents
|
|
AU2006270063A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Applied Biosystems, Llc. |
Methods for RNA profiling
|
|
US8021839B2
(en)
*
|
2006-02-24 |
2011-09-20 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
AU2007304776A1
(en)
|
2006-10-06 |
2008-04-10 |
Dna Genotek Inc. |
Stabilizing compositions and methods for extraction of ribonucleic acid
|
|
WO2008051817A1
(en)
*
|
2006-10-20 |
2008-05-02 |
Novartis Ag |
Compositions and method for monitoring bcr-abl expression
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
CN101173252B
(zh)
*
|
2006-10-31 |
2011-09-21 |
杭州市疾病预防控制中心 |
披甲rna及其制备方法
|
|
US7771947B2
(en)
*
|
2007-02-23 |
2010-08-10 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
US7964350B1
(en)
|
2007-05-18 |
2011-06-21 |
Applied Biosystems, Llc |
Sample preparation for in situ nucleic acid analysis
|
|
WO2009151697A2
(en)
*
|
2008-03-14 |
2009-12-17 |
The Government Of United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and processes relating to human bocavirus
|
|
US8324149B2
(en)
*
|
2008-11-18 |
2012-12-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Encapsidation of heterologous entities into virus-like particles
|
|
US20100129902A1
(en)
*
|
2008-11-24 |
2010-05-27 |
Erhard Ralf Schoenbrunner |
Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
|
|
EP2955233A1
(en)
|
2008-12-19 |
2015-12-16 |
Life Technologies Corporation |
Proteinase K inhibitors, methods and compositions therefor
|
|
JP6121591B2
(ja)
*
|
2010-07-29 |
2017-04-26 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
微生物核酸の定性的および定量的検出
|
|
CN107604097A
(zh)
|
2010-07-29 |
2018-01-19 |
霍夫曼-拉罗奇有限公司 |
用于多种参数的对照核酸
|
|
DE112011102524T5
(de)
|
2010-07-29 |
2013-07-11 |
Roche Diagnostics Gmbh |
Präparation generischer Proben
|
|
CN107190056A
(zh)
*
|
2010-07-29 |
2017-09-22 |
霍夫曼-拉罗奇有限公司 |
微生物核酸的定性和定量检测
|
|
US8877464B2
(en)
|
2010-07-29 |
2014-11-04 |
Roche Molecular Systems, Inc. |
Qualitative and quantitative detection of microbial nucleic acids
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2426222A1
(en)
|
2010-09-07 |
2012-03-07 |
F. Hoffmann-La Roche AG |
Generic buffer for amplification
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2465945A1
(en)
|
2010-12-17 |
2012-06-20 |
F. Hoffmann-La Roche AG |
Generic matrix for control nucleic acids
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
WO2012177656A2
(en)
|
2011-06-19 |
2012-12-27 |
Abogen, Inc. |
Devices, solutions and methods for sample collection
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
SG11201405185PA
(en)
|
2012-03-13 |
2014-10-30 |
Emd Millipore Corp |
Use of centrifugation-aided infection to increase virus titer
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
US9481903B2
(en)
|
2013-03-13 |
2016-11-01 |
Roche Molecular Systems, Inc. |
Systems and methods for detection of cells using engineered transduction particles
|
|
DK2968424T3
(da)
|
2013-03-13 |
2020-03-30 |
Geneweave Biosciences Inc |
Ikke-replikative transduktionspartikler og transduktionspartikelbaserede reportersystemer
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
US9540675B2
(en)
|
2013-10-29 |
2017-01-10 |
GeneWeave Biosciences, Inc. |
Reagent cartridge and methods for detection of cells
|
|
JP2017505143A
(ja)
*
|
2014-02-10 |
2017-02-16 |
アンプテック ゲゼルシャフト ミット ベシュレンクテル ハフツング |
インコーテッドｒｎａ
|
|
PL4023249T3
(pl)
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
GB201412316D0
(en)
*
|
2014-07-10 |
2014-08-27 |
Momentum Bioscience Ltd |
Detecting the absence of micro-organisms
|
|
JP6822974B2
(ja)
|
2015-05-29 |
2021-01-27 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
シトラコン酸無水物によって微生物を不活性化する方法
|
|
US10351893B2
(en)
|
2015-10-05 |
2019-07-16 |
GeneWeave Biosciences, Inc. |
Reagent cartridge for detection of cells
|
|
US20180320199A1
(en)
|
2015-10-28 |
2018-11-08 |
Life Science Inkubator Gmbh |
Use of vlp for the detection of nucleic acids
|
|
US10689689B2
(en)
*
|
2015-12-28 |
2020-06-23 |
Roche Molecular Systems, Inc. |
Generic method for the stabilization of specific RNA
|
|
US20170356025A1
(en)
|
2016-06-14 |
2017-12-14 |
Roche Molecular Systems, Inc. |
Internal control probes for improving pcr assay performance
|
|
EP3299471B1
(en)
|
2016-09-23 |
2019-10-23 |
Roche Diagniostics GmbH |
Methods for determining the amount of a nucleic acid of interest in an unprocessed sample
|
|
US10422012B2
(en)
|
2016-10-10 |
2019-09-24 |
Roche Molecular Systems, Inc. |
Devices comprising bacteriophage PHI6 internal control compositions
|
|
ES2944360T3
(es)
|
2017-10-03 |
2023-06-20 |
Abbott Molecular Inc |
Ensayo para la detección del virus de la inmunodeficiencia humana (VIH)
|
|
CN110892082A
(zh)
|
2017-10-03 |
2020-03-17 |
雅培分子公司 |
丙型肝炎病毒(hcv)的测定
|
|
CA3088866A1
(en)
|
2018-01-09 |
2019-07-18 |
Abbott Molecular Inc. |
Assay for detecting chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis, and mycoplasma genitalium
|
|
JPWO2022045009A1
(https=)
*
|
2020-08-24 |
2022-03-03 |
|
|
|
CN115896243A
(zh)
*
|
2022-11-25 |
2023-04-04 |
上海厦维医学检验实验室有限公司 |
基于混合酶体系的超灵敏反转录方法及其应用
|